The Wyant Simboli Group, Inc.

Home
United States
New Haven, CT
The Wyant Simboli Group, Inc.

Wyant Simboli is a strategic branding firm focused on helping life sciences companies advance. Our experience and expertise are our most valuable assets.

We design corporate communications including corporate identities, websites, investor decks, scientific animation, leadership videos and patient stories. We turn your business objectives into targeted messaging systems, use innovative marketing techniques to help you reach the right audiences, and develop creative design concepts to spread your message effectively. The result is a synchronized com

munications program that seizes the audience’s attention, builds your brand, and helps your company grow.

05/29/2025

Glad to be back at Yale Innovation Summit with founder .wyant. Great to take in latest news in biopharma and reconnect with colleagues.

03/29/2025

Jorge Santos da Silva: Co-Founder and CEO of MoonLake Immunotherapeutics

Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people living with serious inflammatory diseases.

03/03/2025

New BioBoss podcast https://wyantsimboli.com/bioboss/vlad-vitoc-founder-and-ceo-of-maia-biotechnology/ featuring Vlad Vitoc, MD, MBA, founder and CEO of MAIA Biotechnology. Hear Vlad speak with BioBoss host and Wyant Simboli principal John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer.

, , , , , , , ,

Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer.

12/05/2024

Welcome to Season 7 of BioBoss

BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025

11/01/2024

New podcast https://wyantsimboli.com/bioboss/sam-clark-founder-and-ceo-of-terran-biosciences/ featuring Sam Clark, MD PhD, founder and CEO of Terran Biosciences. Hear Sam speak with BioBoss host and Wyant Simboli principal John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neurological and psychiatric diseases

, , , , , , , , , , , , ,

03/26/2024

New BioBoss podcast https://lnkd.in/ePQ28mFd featuring Helen Torley of Halozyme Therapeutics. Hear Helen speak with BioBoss host and Wyant Simboli principal John Simboli about in and how Halozyme, Inc. is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.
, , , , , , , , , , , , , , , ,

01/30/2024

New podcast https://wyantsimboli.com/bioboss/mike-gaffney-ceo-of-cellphire-therapeutics/ featuring Mike Gaffney of Therapeutics, Inc. Hear Mike speak with BioBoss host and Wyant Simboli principal John Simboli about in and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need.

, , , , , , , , , ,
,

01/03/2024

Wyant Simboli wishes a peaceful and joyous 2024 to all!

12/19/2023

New BioBoss podcast https://lnkd.in/eHcdxSkS featuring David Baram, founder and CEO of Emendo Biotherapeutics. Hear David speak with BioBoss host and Wyant Simboli principal John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

, , , , , , , , , , , , , , , , , , ,,

11/08/2023

BioBoss podcast host and Wyant Simboli principal John Simboli is delighted to share insights https://www.wyantsimboli.com/bioboss/anat-binur-co-founder-ceo-of-ukko/ by Anat Binur, Ukko, about in .

04/25/2023

New BioBoss podcast https://www.wyantsimboli.com/bioboss/hartmut-ehrlich-ceo-of-abivax/ featuring Hartmut Ehrlich, CEO of Abivax. Hear Hartmut speak with John Simboli, BioBoss host and principal of WyantSimboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.
, , , , , , , , , , , , , , , , , , , , , , ,

04/04/2023

New BioBoss podcast https://lnkd.in/eZ7jRX6F featuring Ivo Timmermans, CEO Pleco Therapeutics BV. Hear Ivo speak with BioBoss host and Wyant Simboli Principal John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.

Ivo Timmermans, co-founder and CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.

Address

New Haven, CT

Website

http://www.wyantsimboli.com/

Alerts

Be the first to know and let us send you an email when The Wyant Simboli Group, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Our Story

We are are a multi-disciplinary communications design firm. We have 25+ years of experience partnering with companies to define their story, structure their brand, and inspire their audience.